Roche · 8 hours ago
2026 Summer Intern – Department of Biological Chemistry
Roche is a leading company in biotechnology, and they are seeking a 2026 Summer Intern in the Department of Biological Chemistry. This internship will involve learning and performing phage display technology, analyzing Next Generation Sequencing data, and conducting biochemical and biophysical assays.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Learn and perform phage display technology
Apply the phage-display to whole cell panning
Analyzing Next Generation Sequencing data
Utilizing machine learning model for hits optimization
Perform biochemical and biophysical assays with the hits generated from phage display technology
Qualification
Required
Must be pursuing a Bachelor's Degree (enrolled student)
Must have attained a Bachelor's Degree (not currently enrolled in a graduate program)
Must be pursuing a Master's Degree (enrolled student)
Must have attained a Master's Degree
Must be pursuing a PhD (enrolled student)
Required Majors: Chemistry, or Biological Science
Foundational knowledge of molecular biology, biochemistry, and cell biology, OR
Basic chemistry through coursework or laboratory experience
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Basic knowledge on Python coding
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Recent News
GlobeNewswire
2026-01-19
Labiotech UG
2026-01-17
Company data provided by crunchbase